|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 19, 2006
Journal of Experimental Biology 209, 510-517 (2006)
Published by The Company of Biologists 2006
doi: 10.1242/jeb.01973
Corticotropin-releasing hormone-receptor 1 (CRH-R1) and CRH-binding protein (CRH-BP) are expressed in the gills and skin of common carp Cyprinus carpio L. and respond to acute stress and infection
1 Cell Biology and Immunology, Department of Animal Sciences, Wageningen
University, PO Box 338, 6700 AH Wageningen, The Netherlands
2 Department of Animal Physiology, Institute for Neuroscience, Radboud
University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The
Netherlands
* Author for correspondence (e-mail: lidy.vankemenade{at}wur.nl)
Accepted 8 November 2005
| Summary |
|---|
|
|
|---|
Key words: fish, corticotropin-releasing hormone, cRH-BP, cRH-R1, Cyprinus carpio, gills, skin
| Introduction |
|---|
|
|
|---|
CRH expression has been detected in a plethora of mammalian organs
including skin, endometrium, placenta, uterus, ovary, testis, spleen,
pancreas, liver, stomach, small and large intestine, adrenal and thyroid
gland. Furthermore, CRH is produced by various immune cells, including
macrophages (Baker et al.,
2003
) as a proinflammatory agent
(Karalis et al., 1997
), which
is illustrated by the increased CRH expression during experimentally induced
inflammation (Hargreaves et al.,
1989
) or in chronic inflammatory diseases, such as rheumatoid
arthritis (Crofford et al.,
1992
,
1993
).
CRH receptors (CRH-R) have been identified in the skin, adrenal gland,
testis, ovary, prostate, kidney, liver, gut, spleen, circulating immune cells,
synovium, heart, skeletal muscle, uterine myometrium, vascular endothelium,
arterial smooth muscle, endometrium, placenta (reviewed by
Slominski and Wortsman, 2000
),
arterioles, lungs and intestine (Coste et
al., 2002
). CRH-R1 is known to be present in the pituitary gland,
brain and splenic neutrophils, granulocytes, and CRH-R2 is present in the
heart, discrete areas of the brain (Chen et
al., 1993
; Lovenberg et al.,
1995
; Perrin et al.,
1995
; Radulovic et al.,
1999
; Coste et al.,
2002
), skeletal muscle, arterioles, lungs and intestine
(Coste et al., 2002
).
The bioactivity of CRH (and related peptides) depends on CRH-binding
protein (CRH-BP), which determines the concentration of bioavailable CRH and
may influence peptide bioactivity and half-life
(Potter et al., 1991
;
Seasholtz et al., 2002
). As
such CRH-BP may act as a carrier protein that prevents CRH degradation and
facilitates the delivery of peptides to distant sites
(Seasholtz et al., 2002
). The
colocalisation of CRH-BP and CRH in both the rostral pars distalis as well as
in the pars intermedia of carp (Huising et
al., 2004
) substantiates that CRH-BP is also a regulator of CRH in
the pituitary gland of fish.
Many of the effects of peripheral CRH appear to be related to stress
(Dunn and Berridge, 1990
;
Owens and Nemeroff, 1991
;
Rothwell, 1994
;
Tsagarakis and Grossman, 1994
;
Heinrichs et al., 1995
;
Rivest and Rivier, 1995
;
Karalis et al., 1997
;
Webster et al., 1997
;
Turnbull and Rivier, 1999
;
Baigent, 2001
). Acute
immobilisation stress triggers CRH-mediated skin mast cell degranulation, an
action that also involves neurotensin and substance P
(Singh et al., 1999
), and
leads to vasodilation and increased vascular permeability
(Theoharides et al., 1998
).
Furthermore, CRH induces the proliferation of keratinocytes via
interaction with CRH receptors (Mitsuma et
al., 2001
).
Expression of CRH and CRH receptors in human skin has been documented
(Pisarchik and Slominski,
2001
,
2004
). CRH-R1 mRNA expression
was observed in keratinocytes, melanocytes, dermal fibroblasts
(Slominski et al., 2004
) and
circulating immune cells (Slominski et
al., 2001
). Moreover, this expression is regulated by immune
cytokines, UV radiation and skin pathologies
(Slominski et al., 2001
),
factors that are associated with local damage.
Skin and gills in fish are directly and permanently exposed to the environment and thus to multiple physical, chemical and biological influences. A direct, local response of skin and gills to pathogens and chemical and physical stress is envisaged as an important means to guarantee internal homeostasis.
The fish gill is characterized by an extensive and delicate epithelium that
separates the water from the blood. It is a physiologically diversified organ
that serves respiration, osmoregulation, nitrogen excretion and acid-base
balance, which are key processes that are strongly interrelated. The gill is
the only organ that is perfused by the entire cardiac output and has an
extensive vascular surface area in contact with the plasma
(Olson, 1998
); the gills play
a significant, and in some instances dominant, role in endocrine regulation as
an endocrine target as well as metabolically active tissue
(Evans et al., 2005
).
The skin protects the fish against injury and infection and is protected by
a chemically and functionally complex mucus coat that is discharged by mucus
cells in the epidermis. It contains a variety of biologically active compounds
including peroxidase (Iger et al.,
1994
,
1995
;
Brokken et al., 1998
), lysozyme
(Rainger and Rowley, 1993
),
immunoglobulins, complement and C-reactive protein
(Shephard, 1994
).
CRH-BP, CRH-R1 and CRH have been identified in several species of fish,
including carp, in which these proteins have been shown to be involved in the
regulation of the acute stress response
(Huising et al., 2004
). To
date, information on peripheral expression of these factors in fish is
limited.
Given the singular importance of fish gills and skin, we investigated the presence of a local CRH system in these organs. To that end we assessed the expression of CRH, CRH-BP and CRH-R1 and their messengers by immunohistochemistry and real-time quantitative PCR in the gill and skin of carp under normal, stressful and pathological conditions.
| Materials and methods |
|---|
|
|
|---|
Infection with Trypanoplasma borreli
Three weeks before experiments were started, carp (N=14) were
transferred to a quarantine unit and kept in a single experimental tank. The
R3xR8 carp line is trypanotolerant
(Saeij et al., 2003a
). After 3
weeks (t=0) one group (N=8) was injected intramuscularly at
the base of the dorsal fin with 10 000 Trypanoplasma borreli in 100
µl RPMI and was designated the infected group. The control group
(N=6) was injected with 100 µl RPMI and was marked by a small fin
clip. Three weeks post-infection, when parasitaemia reached peak values
(Saeij et al., 2003b
), the
fish were irreversibly anaesthetised. Blood samples were collected for the
determination of haematocrit, leucocrit and parasitaemia.
Restraint period
Two groups of fish (N=8) were housed in identical tanks and after
3 weeks (t=0) one group was restrained for 24 h, bynetting. The other
group did not receive any treatment (controls). Following this 24-h restraint
period, both control and stressed fish were irreversibly anaesthetised. Blood
samples were collected for the determination of haematocrit values as well as
several plasma parameters.
Isolation of head kidney and gill phagocytes
Fish were anaesthetised and blood was collected by puncture of the caudal
vessels. Head kidney and gill phagocytes were isolated as previously described
(Verberg-van Kemenade et al., 1994). Samples of gill and head kidney were
passed through a 50 µm nylon mesh using the barrel from a 10 ml syringe and
suspended in RPMI 1640 medium adjusted to carp osmolarity containing 0.2%
heparin (Leo Pharmaceutical Products, Weesp, The Netherlands). Cell
suspensions were enriched for phagocytes on a 1.07 g cm-3 Percoll
gradient (Amersham Pharmacia Biotech AB, Uppsala, Sweden). The
phagocyte-enriched fraction from the 1.07 Percoll interface was collected and
washed twice with RPMI medium. Viability was assessed by Trypan Blue
exclusion. For RNA isolation 1x107 cells were pelleted and
the RNA was isolated using a RNeasy Mini kit (Qiagen, Valencia, CA, USA)
according to the manufacturer's instructions. For immunohistochemistry the
pelleted cells were fixed in Bouin's solution.
Analysis of CRH, CRH-BP and CRH-R1 gene expression by RQ-PCR
RNA isolation and first strand cDNA synthesis
Gill and skin samples from carp at the end of both infection and restraint
experiments were flash-frozen in liquid nitrogen and stored at -80°C. RNA
was isolated using Trizol (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer's protocol. Single strand cDNA was constructed using Invitrogen
reagents, according to the manufacturer's protocol. Briefly 1 µl 10x
DNAse I reaction buffer and 1 µl DNAse I were added to 1 µg total RNA
and incubated for 15 min at room temperature in a total volume of 10 µl.
DNAse I was inactivated by adding 1 µl 25 mmol l-1 EDTA and
incubated at 65°C for 10 min. To each sample, 300 ng random hexamers, 1
µl 10 mmol l-1 dNTP mix, 4 µl 5x first Strand buffer, 2
µl 0.1 mol l-1 dithiotreitol and 10 U RNAse inhibitor were added
and the mixture was incubated for 10 min at room temperature and an additional
2 min at 37°C. Then, 200 U Superscript RNAse H reverse transcriptase (RT)
was added and the reactions were incubated for 50 min at 37°C. A non-RT
control was included for each sample; cDNA was stored at -20°C.
Real time quantitative PCR
The primers for real time quantitative PCR (RQ-PCR) used in this study were
designed and previously used by Huising et al.
(2004
). For RQ-PCR 5 µl
cDNA and forward and reverse primers (300 nmol l-1 each) were added
to 12.5 µl Sybr Green PCR Master Mix (Applied Biosystems, Foster City, CA,
USA) and made up with demineralised water to a volume of 25 µl. RQ-PCR (2
min 48°C, 10 min 95°C, 40 cycles of 15 s 95°C and 1 min 60°C)
was carried out on a GeneAmp 5700 Sequence Detection System (Applied
Biosystems). Data were analysed with the 
Ct method. Dual
internal standards (40S and ß-actin) were incorporated in all RQ-PCR
experiments and results were confirmed to be very similar following
standardisation to either gene. The amplification efficiencies of all primer
sets in this study are very similar and deviate no more than 5% of the optimal
amplification value of 2.0. Only the results standardised for 40S expression
are shown.
Immunohistochemistry
Samples of gill and skin, and the phagocytes isolated from gills and head
kidney were fixed in Bouin's solution, dehydrated in a graded ethanol series
(70, 80, 90, 95 and 100%), embedded in paraffin, cut into 5 µm sections and
mounted on PolysineTM-coated slides (Menzel-Glazer®, Braunschweig,
Germany).
The histological sections were cleared in Xylol and placed in a solution of
1% H2O2 in methanol (30 min) to remove endogenous
peroxidase activity, rehydrated and washed in phosphate-buffered saline-Triton
X-100 (PBST, 0.1% Triton X-100, pH 7.4) twice (5 and 15 min, respectively).
The sections were incubated (1 h) in a humid chamber at room temperature with
10% normal goat serum in PBST. CRH was detected with a rabbit anti-ovine CRH
(1-41) antiserum (1:100; Biotrend, Cologne, Germany). CRH-BP was detected with
a rabbit anti-human CRH-BP antiserum (hR CRH-BP 254-299; a generous gift from
Prof Dr W. Vale (Potter et al.,
1992
) at a dilution of 1:1000.
Sections were incubated with primary antibodies overnight at 4°C (CRH-BP) or room temperature (CRH). Goat anti-rabbit IgG-biotin (1:200 Vector Laboratories, Burlingame, CA, USA) was used as second antibody followed by amplification using the Vectastain® ABC Amplification Kit (Vector Laboratories) according to the manufacturer's protocol. AEC (3-amino-6-ethylcarbazole; Sigma, St Louis, MO, USA) was used as a substrate. Controls for cross-reactivity of the secondary antibodies and for endogenous enzyme activity were included in all experiments and were negative. Nuclei were counterstained with Haematoxylin. After pre-absorption of the primary antibodies the target cells were negative or in some cases only slightly positive.
Blood analysis
Blood samples were spun down in a cooled (4°C) microcentrifuge (10 min
at 9500 g, IEC micromax RF; Waldham, MA, USA) and the plasma
was collected and stored at -20°C until use. Cortisol was measured by
radioimmunoassay (RIA) as described previously
(Huising et al., 2004
). Plasma
levels of Na+ and K+, glucose, lactate, and the pH were
determined with a Stat Profile®pHOx®Plus (Nova Biomedical, Waldham,
MA, USA, USA).
Cell counting
CRH-BP-positive cells in the gill filaments from the restraint experiment
were quantified in 10 views of the gill filament area using a stereological
overlay method in which a grid was used to estimate the tissue area (in
mm2) (Mazon et al.,
2004
) and the results were expressed as number of cells
mm-2.
Statistical analysis
All statistical analyses were carried out with Graphpad Prism software
(3.0). Differences were evaluated with a Student's t-test,
P<0.05 was taken as fiducial limit.
| Results |
|---|
|
|
|---|
|
|
In the skin some of the CRH- and CRH-BP-positive cells had a similar macrophage-like appearance. CRH-positive cells were observed in the basal layer of the epidermis, close to the melanocytes and also in the dermis (Fig. 3A) and in the fibroblasts of the dermis (Fig. 3B). CRH-BP-positive cells were observed only in the dermis (Fig. 3C,D).
|
CRH- and CRH-BP-positive cells were also observed in the phagocytic fraction from head kidney (not shown) and gills (Fig. 4A,B). Expression of CRH, CRH-BP and CRH-R1 was always detectable in the isolated gill phagocytes (Fig. 4C).
|
|
Expression of CRH-BP and CRH-R1 mRNA in the gills was significantly lower (P<0.05) in the infected group compared with the non infected group (Fig. 5A). In the skin a similar pattern was observed but the effects were not statistically different (Fig. 5B).
|
|
Similar to the infection experiment, expression of CRH-BP and CRH-R1 was
lower (P<0.05) in the stressed compared with the control group, in
both gills and skin (Fig. 6).
This reduced gene expression is paralleled by a lower number of
CRH-BP-positive cells in the gills in the stressed than in the control group
(P<0.05; Fig. 6B).
The total number of macrophage-like cells was also lower in the stressed
group, although this difference was not statistically significant. The
expression of ribosomal 40S and
-actin was unaffected by infection or
24 h restraint.
|
| Discussion |
|---|
|
|
|---|
In mammals, the presence of a cutaneous CRH system is well established.
This system responds to diverse stimuli such as immune cytokines, UV radiation
and skin pathology, in which the common denominator appears to be local damage
(Slominski et al., 2000
). Yet,
the local effects of CRH in mammalian skin are diverse. CRH inhibits
IL-1
-induced prostaglandin synthesis, presumably via
inhibition of cyclo-oxygenase and phospholipase A2
(Fleisher-Berkovich et al.,
1998
). Moreover, direct topic application of CRH to cutaneous or
mucosal tissue evoked vasoconstrictive and anti-inflammatory effects
(Wei and Thomas, 1994
;
McLoon and Wirtschafter, 1997
;
Gjerde et al., 1998
). CRH
injected subcutaneously or intravenously into rats with thermal injury reduced
local fluid accumulation in injured skin of treated animals by over 50%,
independently of the functional activity of the HPI axis (Schafer et al.,
1996
,
1997
). In contrast to these
studies, which suggest a suppressive effect of CRH on local immune activation,
intradermally injected CRH induces local, CRH-R1-dependent mast cell
degranulation and increases vascular permeability
(Theoharides et al., 1998
).
Collectively, these studies indicate that the role of the cutaneous CRH system
is complex, and that the balance between its activation and inhibition may
depend on an interplay with many local as well as systemic parameters.
Acute restraint stress and infection with a blood parasite had marked
effects on different physiological processes. These physiological changes were
in line with expectations, i.e. changes in leucocrit after infection, and
higher cortisol and glucose levels after stress. In addition we have observed
that the tissues composing the external surfaces of carp express all the major
components of a local CRH system, which is reminiscent of the mammalian skin
CRH system. The general response of this integumental CRH system to stress and
infection is similar. This suggests involvement of diverse local and systemic
signals in the local tissue response. The downregulation of CRH-BP and CRH-R1
in gills and skin in response to acute systemic stress suggests that the
transiently elevated plasma cortisol levels exert a negative feedback on
peripheral CRH-R1 and CRH-BP expression, as was reported earlier for carp
pituitary CRH-R1 expression in the same stress paradigm
(Huising et al., 2004
).
Nonetheless, the similar inhibition of gill and skin CRH-BP and CRH-R1
expression observed in the absence of significantly elevated plasma cortisol
levels during T. borreli infection suggests that the expression of
the genes comprising the skin and gill CRH system is locally regulated.
Alternatively, given that CRH and CRH-BP immunoreactivity is at least in part
associated with macrophage-like cells, changes in gene expression may reflect
redistribution of immune cells. Redistribution of immune cells in response to
acute stress (Huising et al.,
2003
) or infection with T. borreli
(Scharsack et al., 2003
) have
been reported earlier in carp and is considered to contribute significantly to
the local immune surveillance.
In carp gills and skin, expression of CRH is detectable but low, which is
reminiscent of the difficulties in detection of CRH gene expression in the
skin of mice (Slominski et al.,
1996
; Slominski and Wortsman,
2000
). Although there are ample CRH immunoreactive cells in both
gills and skin, the markedly lower CRH expression compared to the expression
of CRH-BP and CRH-R1 suggests that the local CRH system responds to systemic
CRH or, alternatively, to CRH-related peptides. We previously observed
pronounced immunoreactivity for CRH and CRH-BP in the pituitary pars nervosa
and suggested their involvement in the regulation of the release of one or
several pituitary pars intermedia peptides
(Huising et al., 2004
).
Alternatively, systemic CRH from the pituitary pars nervosa may be released
directly into circulation and act on peripheral CRH receptors in gills and
skin. Another possible source of ligand is the caudal neurosecretory system or
urophysis, which contains and releases considerable quantities of urotensin-I,
and, in flounder, has very high expression of CRH
(Lu et al., 2004
). Urotensin-I
is a peptide related to CRH that is capable of binding to both CRH-R1 and
CRH-BP (Vaughan et al., 1995
;
Behan et al., 1989
). Urophysial
urotensin-I was initially discovered for its osmoregulatory capacity, and the
fish gills would form a logical target organ for such signal.
We must also consider the possibility that the local CRH system in gills
and skin can be directly and autonomously activated by an external stress.
Gills and skin are strategically located facing the external and internal
environments, and are permanently exposed to stresses and pathogens. These
factors in combination with the key functions that are united in the fish
integument require a constitutive mechanism to deal with stresses while
cellular/tissue damage is still confined and of low magnitude, i.e. before the
systemic stress response is triggered. The observation of CRH-positive cells
in the basal layer is in line with such a mechanism, as basal layer cells have
previously been reported to protect against high copper exposure from the
water (Dang et al., 1999
).
In summary, we have presented evidence for the existence of a local CRH system in teleost fish. This system is responsive to acute systemic stress as well as to prolonged infection with the blood flagellate T. borreli. Therefore, we consider this system analogous to the cutaneous CRH system that has been reported for human and rodent species. Given the presence of similar systems in evolutionary distant vertebrate phyla such as fish and mammals reinforces the importance of a local cutaneous CRH system for the proper and rapid response to various biological, chemical and physical hazards.
| List of abbreviations |
|---|
|
|
|---|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Aguilera, G. (1998). Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol. Met. 9,329 -336.[CrossRef][Medline]
Aguilera, G., Rabadan-Diehl, C. and Nikodemova, M. (2001). Regulation of pituitary corticotropin releasing hormone receptors. Peptides 22,769 -774.[CrossRef][Medline]
Baigent, S. M. (2001). Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22,809 -820.[CrossRef][Medline]
Baker, C., Richards, L. J., Dayan, C. M. and Jessop, D. S. (2003). Corticotropin-releasing hormone immunoreactivity in human T and B cells and macrophages: colocalization with arginine vasopressin. J. Neuroendocrinol. 15,1070 -1074.[CrossRef][Medline]
Behan, D. P., Linton, E. A. and Lowry, P. J.
(1989). Isolation of the human plasma corticotrophin-releasing
factor-binding protein. J. Endocrinol.
122, 23-31.
Brokken, L. J., Verbost, P. M., Atsma, W. and Wendelaar Bonga, S. E. (1998). Isolation, partial characterization and localization of integumental peroxidase, a stress-related enzyme in the skin of teleostean fish (Cyprinus carpio L.). Fish Physiol. Biochem. 18,331 -342.[CrossRef]
Chen, R., Lewis, K. A., Perrin, M. H. and Vale, W. W.
(1993). Expression cloning of a human
corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci.
USA 90,8967
-8971.
Coste, C. S., Quintos, R. F., Stenzel-Poore, M. (2002). Corticotropin-releasing peptides and receptors: Emmergent regulators of cardiovascular adaptations to stress. Trends Cardiovasc. Med. 12,176 -182.[CrossRef][Medline]
Crofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P. and Wilder, R. L. (1992). Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. 90,2555 -2564.[Medline]
Crofford, L. J., Sano, H., Karalis, K., Friedman, T. C., Epps, H. R., Remmers, E. F., Mathern, P., Chrousos, G. P. and Wilder, R. L. (1993). Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151,1587 -1596.[Abstract]
Dang, Z., Lock, R. A., Flik, G. and Wendelaar Bonga, S. E. (1999). Metallothionein response in gills of Oreochromis mossambicus exposed to copper in fresh water. Am. J. Physiol. 277,R320 -R331.[Medline]
Dautzenberg, F. M. and Hauger, R. L. (2002). The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23, 71-77.[CrossRef][Medline]
Dunn, A. J. and Berridge, C. W. (1990). Is corticotropin-releasing factor a mediator of stress responses? Ann. NY Acad. Sci. 579,183 -191.[Medline]
Evans, D. H., Piermarini, P. M. and Choe, K. P.
(2005). The multifunctional fish gill: dominant site of gas
exchange, osmoregulation, acid-base regulation, and excretion of nitrogenous
waste. Physiol. Rev. 85,97
-177.
Fleisher-Berkovich, S., Rimon, G. and Danon, A. (1998). Modulation of endothelial prostaglandin synthesis by corticotropin releasing factor and antagonists. Eur. J. Pharmacol. 353,297 -302.[CrossRef][Medline]
Gjerde, E. A., Woie, K., Wei, E. T. and Reed, R. K. (1998). Corticotropin-releasing hormone inhibits lowering of interstitial pressure in rat trachea after neurogenic inflammation. Eur. J. Pharmacol. 352,99 -102.[CrossRef][Medline]
Hargreaves, K. M., Dubner, R. and Costello, A. H. (1989). Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur. J. Pharmacol. 170,275 -279.[CrossRef][Medline]
Heinrichs, S. C., Menzaghi, F., Merlo Pich, E., Britton, K. T. and Koob, G. F. (1995). The role of CRF in behavioral aspects of stress. Ann. NY Acad. Sci. 771,92 -104.[Medline]
Huising, M. O., Guichelaar, T., Hoek, C., Verburg-van Kemenade, B. M., Flik, G., Savelkoul, H. F. and Rombout, J. H. (2003). Increased efficacy of immersion vaccination in fish with hyperosmotic pretreatment. Vaccine 21,4178 -4193.[CrossRef][Medline]
Huising, M. O., Metz, J. R., van Schooten, C., Taverne-Thiele, A. J., Hermsen, T., Verburg-van Kemenade, B. M. and Flik, G. (2004). Structural characterisation of a cyprinid (Cyprinus carpio L.) CRH, CRH-BP and CRH-R1, and the role of these proteins in the acute stress response. J. Mol. Endocrinol. 32,627 -648.[Abstract]
Iger, Y., Jenner, H. A. and Wendelaar Bonga, S. E. (1994). Cellular responses in the skin of the rainbow trout (Oncorhynchus mykiss) exposed to Rhine water. J. Fish Biol. 45,1119 -1132.[CrossRef]
Iger, Y., Balm, P. H., Jenner, H. A. and Wendelaar Bonga, S. E. (1995). Cortisol induces stress-related changes in the skin of rainbow trout (Oncorhynchus mykiss). Gen. Comp. Endocrinol. 97,188 -198.[CrossRef][Medline]
Irnazarow, I. (1995). Genetic variability of Polish and Hungarian carp lines. Aquaculture 129,215 -219.[CrossRef]
Karalis, K., Muglia, L. J., Bae, D., Hilderbrand, H. and Majzoub, J. A. (1997). CRH and the immune system. J. Neuroimmunol. 72,131 -136.[CrossRef][Medline]
Lovenberg, T. W., Chalmers, D. T., Liu, C. and De Souza, E. B. (1995). CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136,4139 -4142.[Abstract]
Lu, W., Dow, L., Gumusgoz, S., Brierley, M. J., Warne, J. M.,
McCrohan, C. R., Balment, R. J. and Riccardi, D. (2004).
Coexpression of corticotropin-releasing hormone and urotensin i precursor
genes in the caudal neurosecretory system of the euryhaline flounder
(Platichthys flesus): a possible shared role in peripheral
regulation. Endocrinology
145,5786
-5797.
Mazon, A. F., Nolan, D. T., Lock, R. A. C., Fernandes, M. N. and Wendelaar Bonga, S. E. (2004). A short-term in vitro gill culture system to study the effects of toxic (copper) and non-toxic (cortisol) stressors on the rainbow trout, Oncorhynchus mykiss (Walbaum). Toxicol. In Vitro 18,691 -701.[CrossRef][Medline]
McLoon, L. K. and Wirtschafter, J. (1997).
Local injections of corticotropin releasing factor reduce doxorubicin-induced
acute inflammation in the eyelid. Invest. Ophthalmol. Vis.
Sci. 38,834
-841.
Mitsuma, T., Matsumoto, Y. and Tomita, Y. (2001). Corticotropin releasing hormone stimulates proliferation of keratinocytes. Life Sci. 69,1991 -1998.[CrossRef][Medline]
Olson, K. R. (1998). Hormone metabolism by the fish gill. Comp. Biochem. Physiol. 119A,55 -65.
Owens, M. J. and Nemeroff, C. B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43,425 -473.[Medline]
Perrin, M., Donaldson, C., Chen, R., Blount, A., Berggren, T.,
Bilezikjian, L., Sawchenko, P. and Vale, W. (1995).
Identification of a second corticotropin-releasing factor receptor gene and
characterization of a cDNA expressed in heart. Proc. Natl. Acad.
Sci. USA 92,2969
-2973.
Pisarchik, A. and Slominski, A. (2001).
Alternative splicing of CRH-R1 receptors in human and mouse skin:
identification of new variants and their differential expression.
FASEB J. 15,2754
-2756.
Pisarchik, A. and Slominski, A. (2004). Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur. J. Biochem. 271,2821 -2830.[Medline]
Potter, E., Behan, D. P., Fischer, W. H., Linton, E. A., Lowry, P. J. and Vale, W. W. (1991). Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349,423 -426.[CrossRef][Medline]
Potter, E., Behan, D. P., Linton, E. A., Lowry, P. J.,
Sawchenko, P. E. and Vale, W. W. (1992). The central
distribution of a corticotropin-releasing factor (CRF)-binding protein
predicts multiple sites and modes of interaction with CRF. Proc.
Natl. Acad. Sci. USA 89,4192
-4196.
Radulovic, M., Dautzenberg, F. M., Sydow, S., Radulovic, J. and
Spiess, J. (1999). Corticotropin-releasing factor receptor 1
in mouse spleen: expression after immune stimulation and identification of
receptor-bearing cells. J. Immunol.
162,3013
-3021.
Rainger, G. E. and Rowley, A. F. (1993). Antibacterial activity in the serum and mucus of rainbow trout, Oncorhynchus mykiss, following immunisation with Aeromonas salmonicida. Fish Shellfish Immunol. 3, 475-482.[CrossRef]
Rivest, S. and Rivier, C. (1995). The role of
corticotropin-releasing factor and interleukin-1 in the regulation of neurons
controlling reproductive functions. Endocrinol. Rev.
16,177
-199.
Rothwell, N. J. (1994). CNS regulation of thermogenesis. Crit. Rev. Neurobiol. 8, 1-10.[Medline]
Saeij, J. P., de Vries, B. J. and Wiegertjes, G. F. (2003a). The immune response of carp to Trypanoplasma borreli: kinetics of immune gene expression and polyclonal lymphocyte activation. Dev. Comp. Immunol. 27,859 -874.[CrossRef][Medline]
Saeij, J. P., Verburg-van Kemenade, L. B., van Muiswinkel, W. B. and Wiegertjes, G. F. (2003b). Daily handling stress reduces resistance of carp to Trypanoplasma borreli: in vitro modulatory effects of cortisol on leukocyte function and apoptosis. Dev. Comp. Immunol. 27,233 -245.[CrossRef][Medline]
Schafer, M., Mousa, S. A., Zhang, Q., Carter, L. and Stein,
C. (1996). Expression of corticotropin-releasing factor in
inflamed tissue is required for intrinsic peripheral opioid analgesia.
Proc. Natl. Acad. Sci. USA
93,6096
-6100.
Schafer, M., Mousa, S. A. and Stein, C. (1997). Corticotropin-releasing factor in antinociception and inflammation. Eur. J. Pharmacol. 323,1 -10.[CrossRef][Medline]
Scharsack, J. P., Steinhagen, D., Kleczka, C., Schmidt, J. O., Korting, W., Michael, R. D., Leibold, W. and Schuberth, H. J. (2003). The haemoflagellate Trypanoplasma borreli induces the production of nitric oxide, which is associated with modulation of carp (Cyprinus carpio L.) leucocyte functions. Fish Shellfish Immunol. 14,207 -222.[CrossRef][Medline]
Seasholtz, A. F., Valverde, R. A. and Denver, R. J. (2002). Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J. Endocrinol. 175,89 -97.[Abstract]
Shephard, K. L. (1994). Functions for fish mucus. Rev. Fish Biol. Fish. 4, 401-429.[CrossRef]
Singh, L. K., Pang, X., Alexacos, N., Letourneau, R. and Theoharides, T. C. (1999). Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav. Immunol. 13,225 -239.[CrossRef][Medline]
Slominski, A. and Wortsman, J. (2000).
Neuroendocrinology of the skin. Endocrinol. Rev.
21,457
-487.
Slominski, A., Ermak, G., Hwang, J., Mazurkiewicz, J., Corliss, D. and Eastman, A. (1996). The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim. Biophys. Acta 1289,247 -251.[Medline]
Slominski, A., Wortsman, J., Luger, T., Paus, R. and Solomon,
S. (2000). Corticotropin releasing hormone and
proopiomelanocortin involvement in the cutaneous response to stress.
Physiol. Rev. 80,979
-1020.
Slominski, A., Wortsman, J., Pisarchik, A., Zbytek, B., Linton,
E. A., Mazurkiewicz, J. E. and Wei, E. T. (2001). Cutaneous
expression of corticotropin-releasing hormone (CRH), urocortin, and CRH
receptors. FASEB J. 15,1678
-1693.
Slominski, A., Pisarchik, A., Tobin, D. J., Mazurkiewicz, J. E.
and Wortsman, J. (2004). Differential expression of a
cutaneous corticotropin-releasing hormone system.
Endocrinology 145,941
-950.
Theoharides, T. C., Singh, L. K., Boucher, W., Pang, X.,
Letourneau, R., Webster, E. and Chrousos, G. (1998).
Corticotropin-releasing hormone induces skin mast cell degranulation and
increased vascular permeability, a possible explanation for its
proinflammatory effects. Endocrinology
139,403
-413.
Tsagarakis, S. and Grossman, A. (1994). Corticotropin-releasing hormone: interactions with the immune system. Neuroimmunomodulation 1,329 -334.[Medline]
Turnbull, A. V. and Rivier, C. L. (1999).
Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions
and mechanisms of action. Physiol. Rev.
79, 1-71.
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D. and Rivier, C. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378,287 -292.[CrossRef][Medline]
Verburg-van Kemenade, B., Groeneveld, A., Rens, B. and Rombout, J. (1994). Characterization of macrophages and neutrophilic granulocytes from the pronephros of carp (Cyprinus carpio). J. Exp. Biol. 187,143 -158.[Abstract]
Webster, E. L., Elenkov, I. J. and Chrousos, G. P. (1997). The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol. Psychiatry 2, 368-372.[CrossRef][Medline]
Wei, E. T. and Thomas, H. A. (1994). Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. Eur. J. Pharmacol. 263,319 -321.[CrossRef][Medline]
Wendelaar Bonga, S. E. (1997). The stress
response in fish. Physiol. Rev.
77,591
-625.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. O Huising, L. M van der Aa, J. R Metz, A. de Fatima Mazon, B M L. V.-v. Kemenade, and G. Flik Corticotropin-releasing factor (CRF) and CRF-binding protein expression in and release from the head kidney of common carp: evolutionary conservation of the adrenal CRF system J. Endocrinol., June 1, 2007; 193(3): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||